Form 483

Merck Sharp & Dohme LLC Form 483, 2018-10-30

FDA issued a Form 483 to Merck Sharp & Dohme LLC on 2018-10-30 with 4 public-safe observations.

483· Form 483 issuedBiologics4 observations

Merck Sharp & Dohme LLC · Durham, United States · Issued October 30, 2018

Overview

  • 4 public-safe observations are available for this inspection.
  • 4 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

30 Oct 2018
21 CFR 211.113(b)

Procedures for sterile drug products

Cited by Arie Menachem

30 Oct 2018
21 CFR 211.198(a)

Procedures to be written and followed

Cited by Arie Menachem

30 Oct 2018
21 CFR 600.14(a)(1)

Who must report - manufacturer

Cited by Arie Menachem

30 Oct 2018
21 CFR 211.192

Investigations of discrepancies, failures

Cited by Arie Menachem

Inspected site

MSMerck Sharp & Dohme LLCDurham, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.113(b)Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.198(a)Cited across public-safe Form 483 observations1x
21 CFR 600.14(a)(1)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 4 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere